SenesTech Inc. (NASDAQ: SNES) Addressing the Growing Urban Rat Population, and Associated Disease Risks, with Unique EPA-Approved Rat Contraceptives

 

• SenesTech, a rodent fertility control company, through its ContraPest(R) and patent-pending Evolve(TM) soft bait lines, is offering an effective, humane, and safe approach to controlling rat populations, and the diseases rodents can bring with them
• The company’s growing success speaks to the superiority of the company’s offerings, along with the overall effectiveness of its products

SenesTech (NASDAQ: SNES), the inventor of the only EPA-registered contraceptive for male and female rats, recognizes the risks associated with growing rodent populations, especially in cities and areas with a substantial human population. Following its years of experience in the field, the company understands the value of a humane and hygienic approach to controlling rat populations, with non-poison approaches that don’t threaten other animals. This has driven the development of its unique and effective products, and has given it a major competitive edge over its peers in the sector, promoting the company’s rapid and continuing sales increase.

With its fertility control products, SenesTech offers a proven way for entire cities and urban areas to reduce rat populations by over 90%. Available in a variety of delivery systems, SenesTech’s products allow for easy and efficient product deployment, an approach that is achieving significant acceptance in the market (https://ibn.fm/W25DI).

SenesTech’s approach is much needed throughout the industrialized and agricultural world, particularly factoring in how rodents can directly transmit a range of pathogens and disease. They have been known to cause human diseases such as hantavirus, rat bite fever, salmonellosis, and leptospirosis. In addition, these rodents have been known to host pests such as fleas and ticks, which transmit other diseases including, but not limited to, plague, tularemia, Lyme disease, and tickborne relapsing fever (https://ibn.fm/9wDor).

The situation is made worse, given how fast rodents can reproduce. Despite having an average lifespan of 9-12 months, many mice and rat species sexually mature as early as 4-5 weeks of age and have a gestation period of only 21 days. With the right environment, which entails adequate food and warm habitat, rats can have six litters a year, consisting of up to 18 pups each (https://ibn.fm/bw4sV). As such, unless addressed as early as possible, these populations can get out of hand quickly and wreak havoc, both from an environmental and a health perspective.

To address this, SenesTech has been advocating non-lethal rodent birth control products added to or separate from existing integrated pest management plans. Their products can be used separately, or in conjunction with additional rodent control methods.

“The most [effective approach] is combining the elements of integrated pest management and having them work together and support each other,” noted Joel Fruendt, SenesTech’s CEO. (https://ibn.fm/UDul0).

SenesTech’s management is optimistic that as time progresses, more people will learn of the value of its offerings and adopt its solutions. According to them, it speaks of the superiority of its solutions, the company’s market positioning, and the overall value it delivers to its customers.

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

MissionIRNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q1 2024 Financial Results, Earnings Conference Call/Webcast

 Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, will be releasing its first-quarter 2024 financial results this month. The company announced that it will release the report, along with a business update, on May 14, 2024, after the U.S. markets close. The company has also scheduled a conference call and webcast to discuss the release; the call will begin at 5 p.m. ET, also on May 14. Those wishing to access the call can dial 877-407-0789 and use the conference ID 13745868. An archived version of the call will be available on the company’s website.

To access the webcast, visit https://ibn.fm/AIEoH

To view the full press release, visit https://ibn.fm/2BjM2

About Longeveron Inc. 

Longeveron is a clinical-stage, biotechnology company developing regenerative medicines to address unmet medical needs. The company’s lead investigational product is Lomecel-B(TM), an allogeneic medicinal signaling cell (“MSC”) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B(TM) has multiple potential mechanisms of action encompassing provascular, proregenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty. To learn more about the company, visit www.Longeveron.com.

NOTE TO INVESTORS: The latest news and updates relating to LGVN are available in the company’s newsroom at https://ibn.fm/LGVN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

MissionIRNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Announces Launch of Evolve(TM) Mouse to Control Mouse Infestations

 SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced the launch of Evolve(TM) Mouse. Evolve Mouse utilizes a breakthrough fertility solution to control mouse infestations. It is designated as a ‘minimum’ risk product by the U.S. Environmental Protection Agency, posing little to no risk to human health and the environment. SenesTech will be accepting orders as of Monday, May 6, for shipment on or before May 15. According to the announcement, one of the company’s lead distributors and online retailers, DIY Pest Control, has already committed to a sizable preorder and will immediately add Evolve Mouse to their website offerings. The launch of Evolve Mouse follows SenesTech’s introduction of Evolve earlier this year, which is specially formulated for rats. The Evolve product line is the industry’s only soft bait product line to control rodent populations by restricting fertility. “Evolve Mouse is a much-needed extension of the Evolve product line into an underserved market. We would expect the market for a mouse product would at least double the addressable market for the Evolve product line,” said Fletcher Cline, President of DIY Pest Control.

To view the full press release, visit https://ibn.fm/BmxhW

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. The company is an expert in fertility control to manage animal pest populations. It invented ContraPest(R), the only U.S. EPA-registered contraceptive for male and female rats, and Evolve(TM), an EPA-designated minimum risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable. For more information about the company, visit www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

SuperCom Ltd. (NASDAQ: SPCB) Reports Record Revenues, EBITDA and Gross Margin Growth, in Annual Fiscal Conference Call

 

• SuperCom Ltd. is focused on developing its portfolio of products in support of advanced electronic monitoring (“EM”) solutions, and reported last month record-level revenues and EBITDA during the past year
• SuperCom’s recent positive financials report represents the results of the company’s efforts to introduce non-incarceration EM alternatives around the world, with inroads in Europe and the U.S. resulting in significant contracts
• Electronic technology for tracking criminal offenders and other court-administered programs provides a more economical approach to security than incarceration in cases where such options applicable

Electronic-monitoring (“EM”) security solutions developer SuperCom (NASDAQ: SPCB) has seen its revenues and gross margin grow dramatically as it serves a worldwide market for court-administered security needs and other identity technology concerns.

The technology solutions company reported its Q4 and fiscal year-end financial results April 22, noting a 51 percent jump in annual revenue (its third consecutive year of growth), a 60 percent increase in gross profits for the year and a remarkable 2,350 percent burst in its EBITDA (https://ibn.fm/ZiTb4).

The figures include a quarterly increase in the company’s gross margin to 41.4 percent. SuperCom presented the record-level results to investors in a conference call and Q&A on April 22.

“These financial metrics not only underline our strong execution, but also the increasing efficiency and scalability of our operations. During the past year, we won several award contracts in the U.S. and Europe, and we’re excited about the opportunity we see ahead,” CEO and President Ordan Trabelsi said as he introduced the conference call (https://ibn.fm/o9QOH). “Since 2018, SuperCom has secured over 50 new multi-year government projects. Our strong growing reputation as a premium provider of electronic monitoring solutions and services enhanced our market position with each new customer win.”

SuperCom is focused on developing IoT tracking opportunities using its suite of technological products, including PureProtect for domestic violence monitoring, the comprehensive PureOne GPS tracking solution and the PureSecurity platform that is being upgraded with advanced AI integration.

Along with that focus, the company also launched a new project in Iceland that involved upgrades to a system supporting the secured issuance of national ID cards and passports that had previously been deployed.

“This growth is a testament to our competitive edge and ability to secure significant contracts, such as the $33 million national domestic violence project and other multiple high-value projects in Europe and California, reflecting our commitment to excellence and our ability to meet the diverse needs of our international clientele,” Ordan said.

The PureProtect product is particularly important as a solution with life-saving potential. It provides improved protection to families suffering from domestic violence. It was a new rollout during the past year along with PureOne, which delivers a competitive all-in-one GPS tracking ankle bracelet monitoring solution tailored to the North American market.

Ordan said that high recidivism rates and the increasing costs associated with incarceration are making SuperCom’s electronic monitoring solutions an attractive alternative for governments that want to cut their costs while ensuring public safety.

During the past years, SuperCom sealed significant new contracts in a competitive bidding process, allowing the company to expand into 10 new countries in the European market, he reported.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

D-Wave Quantum Inc. (NYSE: QBTS) Announces Fast-Anneal Feature Availability in Leap(TM) Quantum Cloud Service

 

• Fast anneal is expected to impact various quantum computing applications, from advanced scientific research in quantum simulation to AI and solving real-world problems across wide spectrum of industries
• It expands upon D-Wave’s groundbreaking optimization achievements, utilizing the comprehensive coherent annealing quantum computing provided by D-Wave’s Advantage(TM) systems and the cutting-edge Advantage2(TM) prototype
• The introduction of the fast-anneal feature is poised to attract both commercial and academic researchers aiming to develop top-tier applications, broaden benchmarking investigations, and correlate heightened coherence with enhanced performance

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the world’s first commercial supplier of quantum computers, recently announced the launch of the fast-anneal feature, which is available on all D-Wave’s quantum processing units (“QPUs”) in the D-Wave Leap real-time quantum cloud service. Fast anneal is expected to impact a number of quantum computing applications, most notably advanced scientific research.

D-Wave’s fast-anneal feature has been a key part of the company’s research milestones, including published work in Nature Physics (2022) and Nature (2023), demonstrating the advantages of annealing quantum computing over classical algorithms for solving complex optimization problems. Now that this functionality is readily available, customers can conduct quantum computations at remarkable speeds, effectively mitigating the influence of external interferences like temperature changes and background noise, which typically impede quantum calculations.

By providing enhanced control for significantly quicker annealing durations compared to previous options, this feature sets the stage for customers to replicate and expand upon D-Wave’s groundbreaking optimization achievements utilizing the comprehensive coherent annealing quantum computing provided by D-Wave’s Advantage systems and the cutting-edge Advantage2 prototype, the most performant system the company has developed thus far.

“Providing direct access to Fast Anneal, which has been at the heart of D-Wave’s recent advancements, represents a significant step forward in our mission to provide customers with the resources they need to drive innovation and achieve extraordinary results,” said Dr. Alan Baratz, CEO of D-Wave (https://ibn.fm/WgOEf). “We believe it will further empower them to build industry-shaping applications with the most powerful quantum computing environment available today.”

Customer interest in D-Wave’s cutting-edge annealing quantum computing technology is evident through the utilization of its two Advantage2 experimental prototypes, which collectively have addressed almost eight million customer inquiries since their introduction in 2022 and 2024. The new fast-anneal feature is poised to attract both commercial and academic researchers aiming to develop top-tier applications, broaden benchmarking investigations, and correlate heightened coherence with enhanced performance.

Ed Heinbockel, president and CEO of SavantX, a D-Wave customer, welcomed the new functionality, saying that by providing direct access to quantum computing’s central nervous system, D-Wave is single-handedly opening new horizons for research on quantum computing and AI. “We believe the new capability will help us realize significant benefits of coherence on application development that we’d otherwise be unable to achieve,” he added.

The announcement was also praised by Christopher Savoie, co-founder and CEO of Zapata AI, who underlined that the ability to use the fast-anneal feature to directly interact with D-Wave’s Advantage2 prototype is exciting for Zapata AI’s work building quantum-enhanced generative AI models trained on molecular data to accelerate drug discovery and design new materials. “The fast-anneal feature can produce coherent distributions that have the potential to allow more efficient encoding of complex data patterns in a way that is classically impractical,” Savoie added. “In addition to molecular discovery applications, this feature could also be valuable in other industrial applications involving complex data patterns, particularly in combinatorial optimization problems found across industries.”

D-Wave’s customers include over two dozen Forbes Global 2000 companies and blue-chip industry leaders like Mastercard, Deloitte, Unisys, NEC Corporation, DENSO, and more. Their client success stories can be found on the company’s website (https://ibn.fm/aDOwo).

For more information, visit the company’s website at www.DWaveQuantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN